Drug Trial Radar · NCT02285140
Prevention of Infections in Cardiac Surgery
Last checked: Nov 19, 2026Latest source record: Mar 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
5,989
Actual
Start
Apr 2015
Primary completion
Mar 10, 2025
Study completion Mar 10, 2025
Sponsor
- Lead sponsor
- Hamilton Health Sciences CorporationAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- The Physicians' Services Incorporated Foundation
- First posted
- Nov 6, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
There is clinical equipoise about the question of whether antibiotic prophylaxis should be given for a short period or an extended period of time as reflected by inconsistencies in major guidelines, current practices at Canadian centers, and as concluded in the three systematic reviews. There also is clinical equipoise on whether the addition of vancomycin to routine cefazolin prophylaxis can further reduce s-SSI rates. A short duration of combined antimicrobial prophylaxis can reduce side effects of exposure to antimicrobials such as infections with C. difficile or emergence of resistance, but may also reduce the incidence of s-SSIs. The objective of the eventual full scale study is to determine whether adding vancomycin to cefazolin can reduce SSIs as well as whether short-term prophylaxis is as effective as long-term prophylaxis. The rationale to conduct the proposed pilot study is to assess the feasibility to conduct this factorial cluster randomized cross-over trial, the adherence to the study protocol at each pilot site, the length of time to fill out the case report forms, and to get reliable estimates of event rates for sample size calculation for the main study
Conditions
- Thoracic Surgery
- Antibiotic Prophylaxis
Interventions
CefazolinDrug
administration as outlined
VancomycinDrug
administration as outlined
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of patients receiving antibiotics according to study protocolTime frame: 3 months post-surgery
- Proportion of patients with complete follow-up, i.e. up to 90 days or death; goal >95%Time frame: 3 months post-surgery
- Agreement of blinded outcome assessment based on information from the case report formTime frame: 3 months post-surgery
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Hamilton Health Sciences
Hamilton, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Jewish Hospital
Montreal, Quebec, Canada
University of Sherbrook
Sherbrook, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.